Steven L. Hoerter
Board Member
C4 Therapeutics, Inc. (CCCC)Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsAbout Steven L. Hoerter
Steven L. Hoerter is recorded as Board Member at C4 Therapeutics, Inc. (CCCC) since November 19, 2024. C4 Therapeutics, Inc. reported in an 8-K filed November 20, 2024 that Steven L. Hoerter was appointed director, effective November 19, 2024. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.
“On November 19, 2024, the Board of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "NCG Committee"), appointed Steven L. Hoerter as a director of the Company.”
Affiliation history
-
Current
2024-11-19–present
Company network
Leadership on record at C4 Therapeutics, Inc.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White CFO, Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member